BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Fundraising marketing - Theoria Creative - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Biotech events - Theoria Creative
X-ORIGINAL-URL:https://theoriacreative.com
X-WR-CALDESC:Events for Fundraising marketing - Theoria Creative
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240328
DTSTAMP:20260811T061304
CREATED:20240608T161436Z
LAST-MODIFIED:20240608T184434Z
UID:10727-1711411200-1711583999@theoriacreative.com
SUMMARY:Pharma USA - Reuters Events
DESCRIPTION:North America’s largest cross-functional pharma gathering \nRapid healthcare reforms are finally paving the way for affordable access to medicines\, but your commercial model is now outdated. The future of life-saving treatments reaching patients is under threat. \nThe race is on to adapt. How quickly you can create and scale patient value to competing stakeholders will determine whether future scientific innovation will succeed. Those afraid to accelerate will be left behind. \nWe must empower HCPs with crucial insights\, adapt to evolving payer needs\, scale with digital & tech and co-create with patients. Only then will we achieve exceptional outcomes and prove to be a trusted ally. \nReuters Events: Pharma USA 2024 is where pioneers from Commercial\, Marketing\, Medical Affairs\, RWE\, Market Access\, Patient Engagement\, and key stakeholders\, will come together to deliver value to overcome the challenges that threaten the future viability of innovation. \nJoin over 1\,200 of North America’s pharma pioneers\, leading solutions providers\, and patient advocates to sharpen short-term strategy and unite for a long-term future to exceed all stakeholder desires and cement pharma’s role as an integral pillar of the healthcare system.
URL:https://theoriacreative.com/calendar/pharma-usa-reuters-events/
LOCATION:CA
CATEGORIES:Investors
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240328
DTSTAMP:20260811T061304
CREATED:20240608T161449Z
LAST-MODIFIED:20240608T184749Z
UID:10728-1711411200-1711583999@theoriacreative.com
SUMMARY:Cell & Gene Therapy at Pharma USA 2024
DESCRIPTION:Accelerate innovation commercialization. Expand market footprint with proven potential. \nWith so many scientific breakthroughs in regenerative medicine\, commercial challenges have never been so urgent. Consequences have been suffered by both pharma and patients when we fail to overcome the barriers from lab to sites of care. \nTo continuedly create impact from trial to post-launch\, we must proactively work with patients\, HCPs\, regulators\, payors and partners to amplify the values of innovation for all stakeholders\, and eventually will be able to expand our footprint and pave the road to the next generation medicine. \nRome wasn’t built in a day\, but at Pharma USA 2024 (March 26-27\, Philadelphia) we’re laying the foundations for your frontline therapy by gathering the industry’s best minds and generating solutions to the space’s biggest commercial challenges.
URL:https://theoriacreative.com/calendar/cell-gene-therapy-at-pharma-usa-2024/
LOCATION:CA
CATEGORIES:Investors
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240330
DTSTAMP:20260811T061304
CREATED:20240608T161450Z
LAST-MODIFIED:20240608T184832Z
UID:10729-1711411200-1711756799@theoriacreative.com
SUMMARY:Gene Therapy for Rare Disorders Summit
DESCRIPTION:This past year has seen more gene therapies approved by the FDA than the previous five years combined\, and almost triple the number of clinical trials in gene therapy have been initiated in H1 of 2023 compared to the same time frame in the previous year. \nTo maximize the value of your late-stage gene therapy assets\, the 7th Gene Therapy for Rare Disorders Summit is returning to tackle head-on the significant clinical\, manufacturing\, regulatory\, and commercial challenges facing gene therapy programs today. \nBringing together key figures from industry\, regulatory bodies\, patient non-profits\, payers\, and key service providers\, this is the field’s foremost meeting for collectively progressing rare gene therapy programs into and through the clinic. \nJoin us to leverage essential insights from over 300 peers from leading biopharma companies with direct experience in driving gene therapies through the clinic and into the market. Keep your finger on the pulse\, form connections with top decision-makers\, and address your specific clinical\, manufacturing\, regulatory\, and commercial bottlenecks to safeguard against costly delays and progress your gene therapies through the pipeline quickly and safely.
URL:https://theoriacreative.com/calendar/gene-therapy-for-rare-disorders-summit/
LOCATION:CA
CATEGORIES:Scientific
END:VEVENT
END:VCALENDAR